Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 165.45M P/E - EPS this Y 29.20% Ern Qtrly Grth -
Income -197.68M Forward P/E -1.44 EPS next Y -8.00% 50D Avg Chg -53.00%
Sales - PEG -0.05 EPS past 5Y - 200D Avg Chg -52.00%
Dividend N/A Price/Book 0.42 EPS next 5Y 12.40% 52W High Chg -75.00%
Recommedations 3.30 Quick Ratio 10.34 Shares Outstanding 52.61M 52W Low Chg 14.00%
Insider Own 5.66% ROA -26.72% Shares Float 32.20M Beta 2.34
Inst Own 76.99% ROE -71.50% Shares Shorted/Prior 1.79M/1.86M Price 3.16
Gross Margin - Profit Margin - Avg. Volume 1,184,417 Target Price 2.75
Oper. Margin - Earnings Date Nov 12 Volume 1,009,541 Change 5.33%
About Kodiak Sciences Inc

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate targeting the pro-inflammatory cytokine interleukin-6 (IL-6) and VEGF; and KSI-101 (KSI-501P), an unconjugated bispecific protein targeting IL-6 and VEGF developed for retinal inflammatory conditions. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.

Kodiak Sciences Inc News
09/13/24 Why Is Kodiak Sciences (KOD) Down 8.1% Since Last Earnings Report?
09:42 AM Kodiak (KOD) Q2 Loss Narrower Than Expected, Pipeline in Focus
08/14/24 Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2024 Financial Results
07/21/24 Kodiak Sciences Inc. (NASDAQ:KOD) is definitely on the radar of institutional investors who own 50% of the company
07/10/24 All You Need to Know About Kodiak Sciences (KOD) Rating Upgrade to Buy
06/20/24 Should You Hold Kodiak Sciences (KOD) Stock in Your Portfolio?
06/14/24 Why Is Kodiak Sciences (KOD) Down 26.2% Since Last Earnings Report?
05/29/24 Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences
11:51 AM Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus
05/15/24 Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results
05/14/24 Kodiak Sciences dosing subjects in Phase III trial of diabetic retinopathy drug
05/13/24 Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy
05/02/24 Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform
04/11/24 Will Kodiak Sciences (NASDAQ:KOD) Spend Its Cash Wisely?
04/04/24 Kodiak (KOD) Counts on Tarcocimab Program Despite Setbacks
04/01/24 Kodiak Sciences Inc. (NASDAQ:KOD) Q4 2023 Earnings Call Transcript
04/01/24 Kodiak (KOD) Stock Falls on Q4 Earnings Miss, Pipeline in Focus
03/29/24 Q4 2023 Kodiak Sciences Inc Earnings Call
03/28/24 Kodiak Sciences Inc (KOD) Posts Q4 and Full Year 2023 Financial Results
03/28/24 Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
KOD Chatroom

User Image gabbar111 Posted - 3 days ago

$KOD The company plans to host an Investor Day on September 23, 2024.

User Image biomaster22 Posted - 5 days ago

$KOD hey Victor sept 3/4 year over and you have said nothing about trials what the F are you guys doing there besides pissing away our money ! BB where teh heck are you !

User Image IN0V8 Posted - 1 week ago

$KOD H.C. Wainwright initiates coverage with neutral rating

User Image RallyRaider Posted - 1 week ago

$KOD can decide its fate here .... might break the old downtrend

User Image biomaster22 Posted - 08/29/24

$KOD what a POS penny stock !

User Image insidemoney Posted - 08/27/24

$KOD Kodiak Sciences Inc. 14-Day RSI: 58.7 % from 52-Week Low: +113.1% % from 52-Week High: -62.4% Open Interest: 1,446 % Change: 0% Put/Call Ratio: 0.8 % Change: -0.1%

User Image Sterling7272 Posted - 08/23/24

$KOD for fucks sake….. is this ever going to hit $3 again?????

User Image adayxs Posted - 08/20/24

$KOD I just read this. Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2024 Financial Results It looks like they will not have enough cash to bring this to market. What is the plan?

User Image Shadowplays Posted - 08/19/24

$KOD

User Image biomaster22 Posted - 1 month ago

$KOD total POS - FU BB and Victor your shares are worthless !

User Image kinderspiel Posted - 1 month ago

Aug 15 highest volume of shares traded $CYTK 260.2 k $TWST 214.1 k $PBYI 146.5 k $KOD 78.6 k $KRYS 23.3 k

User Image epsguid Posted - 1 month ago

$KOD reported a loss of $0.86, consensus was ($0.87) via @eWhispers #epsbeat http://eps.sh/d/kod

User Image RockyTSTH Posted - 1 month ago

$KOD Kodiak Sciences Q2 EPS $(0.86) Beats $(1.19) Estimate

User Image Stock_Titan Posted - 1 month ago

$KOD Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2024 Financial Results https://www.stocktitan.net/news/KOD/kodiak-sciences-announces-recent-business-highlights-and-second-xi7d19mmn08t.html

User Image biomaster22 Posted - 1 month ago

$KOD Victor are you awake - maybe you fools can announce a quarterly update on how you have nothing going on until end of the year and are just burning shareholder cash ! Losers

User Image Nibbler Posted - 1 month ago

$KOD Does those ticker still trade?

User Image biomaster22 Posted - 1 month ago

$KOD Thanks Victor and BB you might have the worst performing stock in the last 5 years - great job you bunch of fools, you should be so proud!

User Image NVDAMillionaire Posted - 07/31/24

$KOD Kodiak Sciences Inc. (NASDAQ:KOD): Navigating the Retina Landscape with a Diversified Pipeline http://beyondspx.com/2024/07/30/kodiak-sciences-inc-nasdaqkod-navigating-the-retina-landscape-with-a-diversified-pipeline/

User Image biomaster22 Posted - 07/29/24

$KOD what a Joke! wiped out all gains from the last two weeks - FU Victor !

User Image biomaster22 Posted - 07/26/24

$KOD if victor and BB own 75% of outstanding shares who the fck is selling at $3.00

User Image greensmell Posted - 07/23/24

$OCUL if you recall $kod was trading over $6b before their lead drug failed in phase 3. While market dynamics were a little different back then, I don't see how a company like ocular can't be at least $3b given such diverse pipeline and an already approved product.

User Image biomaster22 Posted - 07/23/24

$KOD headfake or can we hold 3 and start the push to 4?

User Image Sterling7272 Posted - 2 months ago

$KOD Jesus…. Is everyone under water on this one like I am?? SOB’s been stuck at 2.50 for what feels like forever. Nice to see it finally in the 3’s. Any guesses on how long it’ll take to get to $5?

User Image gorskyninja Posted - 2 months ago

$KOD wow

User Image biomaster22 Posted - 2 months ago

$KOD FU - Felix, Julian and Victor 3 Stooges!

User Image MadMaverick Posted - 2 months ago

$DUST $OVID $KOD $CHPT $SOUN

User Image AidenB Posted - 2 months ago

$KOD I wouldn't be surprised if this goes to $18 on news for continuation expectations on one or more indicators

User Image MadMaverick Posted - 2 months ago

$CHPT $DUST $KOD $OVID $SOUN

User Image gorskyninja Posted - 2 months ago

$KOD fuck. I shoulda loaded up at the low 2s

User Image MadMaverick Posted - 2 months ago

Update for this week's Top 5 Swing Picks 🟢 $CHPT - 18% profit potential 🟢 $KOD - 22% profit potential 🟢 $OVID - 36% profit potential 🟢 $SOUN - 51% profit potential 🔴 $DUST - Stopped out 10% loss Sign up for next week's Top 5 picks! 👇🏻 Link in my profile. See you there.

Analyst Ratings
HC Wainwright & Co. Neutral Sep 5, 24
UBS Neutral Apr 4, 24
Barclays Underweight Apr 1, 24
UBS Neutral Dec 21, 23
Capital One Overweight Nov 17, 23
UBS Neutral Jul 27, 23
Chardan Capital Neutral Jul 25, 23
Barclays Underweight Jul 25, 23
JP Morgan Underweight Jul 25, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
EHRLICH JASON See Remarks See Remarks Jun 14 Sell 9.33 3,390 31,629 61,924 06/16/23
BORGESON JOHN A. See Remarks See Remarks Jun 14 Sell 9.33 4,197 39,158 178,077 06/16/23
EHRLICH JASON See Remarks See Remarks Jun 15 Sell 7.12 3,487 24,827 56,920 06/17/22
BORGESON JOHN A. See Remarks See Remarks Jun 15 Sell 7.12 4,343 30,922 173,755 06/17/22
BAKER BROS. ADVISORS LP Director Director Jun 02 Buy 7.77 572,349 4,447,152 15,967,504 06/06/22
BAKER BROS. ADVISORS LP Director Director May 16 Buy 5.9 456,690 2,694,471 15,142,074 05/18/22
PERLROTH VICTOR Chairman and CEO Chairman and CEO Feb 24 Sell 9.09 1,340,000 12,180,600 2,168,038 02/28/22
BAKER BROS. ADVISORS LP Director Director Feb 15 Buy 54.11 400,965 21,696,216 14,734,965 02/17/22
BAKER BROS. ADVISORS LP Director Director Jan 27 Buy 52.1 347,665 18,113,346 14,364,512 01/31/22
BAKER BROS. ADVISORS LP Director Director Jan 21 Buy 57.62 501,111 28,874,016 14,027,837 01/25/22
EHRLICH JASON See Remarks See Remarks Jan 20 Option 10.29 6,950 71,516 58,491 01/24/22
EHRLICH JASON See Remarks See Remarks Jan 20 Sell 64.9 6,950 451,055 51,541 01/24/22
EHRLICH JASON See Remarks See Remarks Oct 20 Option 10.29 6,950 71,516 58,491 10/22/21
EHRLICH JASON See Remarks See Remarks Oct 20 Sell 112.15 6,950 779,442 51,541 10/22/21
BAKER BROS. ADVISORS LP Director Director Sep 09 Buy 93.12 57,501 5,354,493 13,269,155 09/09/21